Access cutting-edge lgmd2i treatment through this clinical trial at a research site in Iowa City. Study-provided care at no cost to qualified participants.
Access lgmd2i specialists in Iowa City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lgmd2i treatment provided free
The purpose of this study is to evaluate the safety and tolerability of a single intravenous infusion of AB-1003 in adults diagnosed with limb girdle muscular dystrophy type 2I/R9 (LGMD2I/R9). Participants will be treated in sequential, dose-level cohorts. (Part 1)
Sponsor: AskBio Inc
Check if you qualify for this lgmd2i clinical trial in Iowa City, IA
If you're searching for lgmd2i treatment options in Iowa City, IA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Iowa City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lgmd2i specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.